Research & Literature

Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review.

Levey AS, Becker C, Inker LA

JAMA 2015; (313(8)):837-46 doi:10.1001/jama.2015.0602.

Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report.

Eckardt KU, Alper SL, Antignac C, et al.

Kidney international 2015; (88(4)):676-83 doi:10.1038/ki.2015.28.

Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.

Park HC, Kang AY, Jang JY, et al.

BMC nephrology 2015; (16()):86 doi:10.1186/s12882-015-0075-8.

Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database.

Watkins PB, Lewis JH, Kaplowitz N, et al.

Drug safety 2015; (38(11)):1103-13 doi:10.1007/s40264-015-0327-3.

Hypomagnesemia as First Clinical Manifestation of ADTKD-HNF1B: A Case Series and Literature Review.

van der Made CI, Hoorn EJ, de la Faille R, et al.

American journal of nephrology 2015; (42(1)):85-90 doi:10.1159/000439286.

Ambulatory and home blood pressure monitoring in people with chronic kidney disease. Time to abandon clinic blood pressure measurements?

Ruiz-Hurtado G, Gorostidi M, Waeber B, Ruilope LM

Current opinion in nephrology and hypertension 2015; (24(6)):488-91 doi:10.1097/MNH.0000000000000162.

Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician.

Vassalotti JA, Centor R, Turner BJ, et al.

The American journal of medicine 2016; (129(2)):153-162.e7.

Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial.

Torres VE, Higashihara E, Devuyst O, et al.

Clinical journal of the American Society of Nephrology : CJASN 2016; (11(5)):803-811 doi:10.2215/CJN.06300615.

[Clinical diagnosis of Autosomal Dominant Polycystic Kidney Disease].

Magistroni R, Izzi C, Scolari F

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 2016; (33(2)).

Acute Kidney Injury in Elderly Patients With Chronic Kidney Disease: Do Angiotensin-Converting Enzyme Inhibitors Carry a Risk?

Chaumont M, Pourcelet A, van Nuffelen M, et al.

Journal of clinical hypertension (Greenwich, Conn.) 2016; (18(6)):514-21 doi:10.1111/jch.12795.

Hypertension in Chronic Kidney Disease.

Hamrahian SM, Falkner B

Advances in experimental medicine and biology 2017; (956()):307-325 doi:10.1007/5584_2016_84.

Chronic Kidney Disease.

Webster AC, Nagler EV, Morton RL, Masson P

Lancet (London, England) 2017; (389(10075)):1238-1252 doi:10.1016/S0140-6736(16)32064-5.

Pharmacokinetics and Pharmacodynamics of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Phase 2 Trials for Dose Selection in the Pivotal Phase 3 Trial.

Shoaf SE, Chapman AB, Torres VE, et al.

Journal of clinical pharmacology 2017; (57(7)):906-917 doi:10.1002/jcph.880.

Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup.

Chawla LS, Bellomo R, Bihorac A, et al.

Nature reviews. Nephrology 2017; (13(4)):241-257 doi:10.1038/nrneph.2017.2.

Autosomal Dominant Tubulointerstitial Kidney Disease.

Bleyer AJ, Kidd K, Živná M, Kmoch S

Advances in chronic kidney disease 2017; (24(2)):86-93 doi:10.1053/j.ackd.2016.11.012.

Polycystic Kidney Disease without an Apparent Family History.

Iliuta IA, Kalatharan V, Wang K, et al.

Journal of the American Society of Nephrology : JASN 2017; (28(9)):2768-2776 doi:10.1681/ASN.2016090938.

Discovery of a novel dominant mutation in the REN gene after forty years of renal disease: a case report.

Clissold RL, Clarke HC, Spasic-Boskovic O, et al.

BMC nephrology 2017; (18(1)):234 doi:10.1186/s12882-017-0631-5.

Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project.

Bandak G, Sang Y, Gasparini A, et al.

Journal of the American Heart Association 2017; (6(7)) doi:10.1161/JAHA.116.005428.

Urinary renin-angiotensin markers in polycystic kidney disease.

Salih M, Bovée DM, Roksnoer LCW, et al.

American journal of physiology. Renal physiology 2017; (313(4)):F874-F881 doi:10.1152/ajprenal.00209.2017.

Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders.

Mallett AJ, McCarthy HJ, Ho G, et al.

Kidney international 2017; (92(6)):1493-1506 doi:10.1016/j.kint.2017.06.013.

[Management of Patients with CKD in Clinical Practice].

Dabers T, Weckmann G, Chenot JF, Stracke S

Deutsche medizinische Wochenschrift (1946) 2017; (142(17)):1290-1298 doi:10.1055/s-0043-108466.

Tolerability of Aquaretic-Related Symptoms Following Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Results From TEMPO 3:4.

Devuyst O, Chapman AB, Shoaf SE, et al.

Kidney international reports 2017; (2(6)):1132-1140 doi:10.1016/j.ekir.2017.07.004.

Hypertension.

Oparil S, Acelajado MC, Bakris GL, et al.

Nature reviews. Disease primers 2018; (4()):18014 doi:10.1038/nrdp.2018.14.

A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan.

Chebib FT, Perrone RD, Chapman AB, et al.

Journal of the American Society of Nephrology : JASN 2018; (29(10)):2458-2470 doi:10.1681/ASN.2018060590.

Treatment of Hypertensive Cardiogenic Edema with Intravenous High-Dose Nitroglycerin in a Patient Presenting with Signs of Respiratory Failure: A Case Report and Review of the Literature.

López-Rivera F, Cintrón Martínez HR, Castillo LaTorre C, et al.

The American journal of case reports 2019; (20()):83-90 doi:10.12659/AJCR.913250.

Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease.

Blair HA

Drugs 2019; (79(3)):303-313 doi:10.1007/s40265-019-1056-1.

Renin-angiotensin system inhibitors in hypertensive adults with non-diabetic CKD with or without proteinuria: a systematic review and meta-analysis of randomized trials.

Mishima E, Haruna Y, Arima H

Hypertension research : official journal of the Japanese Society of Hypertension 2019; (42(4)):469-482 doi:10.1038/s41440-018-0116-3.

Quantifying lead time bias when estimating patient survival in preemptive living kidney donor transplantation.

Irish GL, Chadban S, McDonald S, Clayton PA

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2019; (19(12)):3367-3376 doi:10.1111/ajt.15472.

Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease.

Ali S, Dave N, Virani SS, Navaneethan SD

Current atherosclerosis reports 2019; (21(9)):32 doi:10.1007/s11883-019-0794-6.

[Spironolactone in resistant essential hypertension].

Lorthioir A, Belmihoub I, Fouassier D, et al.

Presse medicale (Paris, France : 1983) 2019; (48(12)):1431-1438 doi:10.1016/j.lpm.2019.07.027.

Autosomal dominant tubulointerstitial kidney disease.

Devuyst O, Olinger E, Weber S, et al.

Nature reviews. Disease primers 2019; (5(1)):60 doi:10.1038/s41572-019-0109-9.

Atrial septal defects, supravalvular aortic stenosis and syndromes predisposing to aneurysm of large vessels.

Baglivo M, Dassati S, Krasi G, et al.

Acta bio-medica : Atenei Parmensis 2019; (90(10-S)):53-57 doi:10.23750/abm.v90i10-S.8760.

Utility of Genomic Testing after Renal Biopsy.

Murray SL, Dorman A, Benson KA, et al.

American journal of nephrology 2020; (51(1)):43-53 doi:10.1159/000504869.

Blood Pressure Measurement: A KDOQI Perspective.

Drawz PE, Beddhu S, Kramer HJ, et al.

American journal of kidney diseases : the official journal of the National Kidney Foundation 2020; (75(3)):426-434 doi:10.1053/j.ajkd.2019.08.030.

Proteinuria-take a closer look!

Bökenkamp A

Pediatric nephrology (Berlin, Germany) 2020; (35(4)):533-541 doi:10.1007/s00467-019-04454-w.

Renal transplant outcomes in patients with autosomal dominant tubulointerstitial kidney disease.

Cormican S, Kennedy C, Connaughton DM, et al.

Clinical transplantation 2020; (34(2)):e13783 doi:10.1111/ctr.13783.

Dickkopf 3-a novel biomarker of the 'kidney injury continuum'.

Schunk SJ, Speer T, Petrakis I, Fliser D

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2021; (36(5)):761-767 doi:10.1093/ndt/gfaa003.

Exome Sequencing and Identification of Phenocopies in Patients With Clinically Presumed Hereditary Nephropathies.

Riedhammer KM, Braunisch MC, Günthner R, et al.

American journal of kidney diseases : the official journal of the National Kidney Foundation 2020; (76(4)):460-470 doi:10.1053/j.ajkd.2019.12.008.

Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1.

Olinger E, Hofmann P, Kidd K, et al.

Kidney international 2020; (98(3)):717-731 doi:10.1016/j.kint.2020.04.038.

The prevalence of chronic kidney disease in Iceland according to KDIGO criteria and age-adapted estimated glomerular filtration rate thresholds.

Jonsson AJ, Lund SH, Eriksen BO, et al.

Kidney international 2020; (98(5)):1286-1295 doi:10.1016/j.kint.2020.06.017.

Sodium Intake and Chronic Kidney Disease.

Borrelli S, Provenzano M, Gagliardi I, et al.

International journal of molecular sciences 2020; (21(13)) doi:10.3390/ijms21134744.

Management Options for an Older Adult With Advanced Chronic Kidney Disease and Dementia: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.

Burns RB, Waikar SS, Wachterman MW, Kanjee Z

Annals of internal medicine 2020; (173(3)):217-225 doi:10.7326/M20-2640.

KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update.

Lok CE, Huber TS, Lee T, et al.

American journal of kidney diseases : the official journal of the National Kidney Foundation 2020; (75(4 Suppl 2)):S1-S164 doi:10.1053/j.ajkd.2019.12.001.

Blood pressure control in patients with chronic kidney disease according to office and home blood pressures.

Chantrel F, Ott J, Dimitrov Y, et al.

Blood pressure monitoring 2020; (25(5)):246-251 doi:10.1097/MBP.0000000000000463.

Health-related quality of life in patients with chronic kidney disease.

Hussien H, Apetrii M, Covic A

Expert review of pharmacoeconomics & outcomes research 2021; (21(1)):43-54 doi:10.1080/14737167.2021.1854091.

Variable Expressivity of HNF1B Nephropathy, From Renal Cysts and Diabetes to Medullary Sponge Kidney Through Tubulo-interstitial Kidney Disease.

Izzi C, Dordoni C, Econimo L, et al.

Kidney international reports 2020; (5(12)):2341-2350 doi:10.1016/j.ekir.2020.09.042.

Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.

Torres VE, Chapman AB, Devuyst O, et al.

Clinical journal of the American Society of Nephrology : CJASN 2020; (16(1)):48-58 doi:10.2215/CJN.10250620.

Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players.

Domingo-Gallego A, Pybus M, Bullich G, et al.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2022; (37(4)):687-696 doi:10.1093/ndt/gfab019.

Risk factors for hypertensive crisis in adult patients: a systematic review.

Benenson I, Waldron FA, Jadotte YT, et al.

JBI evidence synthesis 2021; (19(6)):1292-1327 doi:10.11124/JBIES-20-00243.

Familial juvenile hyperuricemia in early childhood in a boy with a novel gene mutation.

Takemasa Y, Hirano D, Kawakami Y, et al.

CEN case reports 2021; (10(3)):426-430 doi:10.1007/s13730-020-00566-7.

Racial Disparities in Eligibility for Preemptive Waitlisting for Kidney Transplantation and Modification of eGFR Thresholds to Equalize Waitlist Time.

Ku E, McCulloch CE, Adey DB, et al.

Journal of the American Society of Nephrology : JASN 2021; (32(3)):677-685 doi:10.1681/ASN.2020081144.

Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.

Cheung AK, Chang TI, Cushman WC, et al.

Kidney international 2021; (99(3)):559-569 doi:10.1016/j.kint.2020.10.026.

The wind of change in the management of autosomal dominant polycystic kidney disease in childhood.

Gimpel C, Bergmann C, Mekahli D

Pediatric nephrology (Berlin, Germany) 2022; (37(3)):473-487 doi:10.1007/s00467-021-04974-4.

Increasing prevalence of hypertension during long-term follow-up in children with autosomal dominant polycystic kidney disease.

Seeman T, Jansky P, Filip F, et al.

Pediatric nephrology (Berlin, Germany) 2021; (36(11)):3717-3723 doi:10.1007/s00467-021-05104-w.

Autosomal dominant tubulointerstitial kidney disease: more than just HNF1β.

Bleyer AJ, Wolf MT, Kidd KO, et al.

Pediatric nephrology (Berlin, Germany) 2022; (37(5)):933-946 doi:10.1007/s00467-021-05118-4.

Application of single-sperm sequencing in a male with Marfan syndrome: a case report and a literature review.

Li C, Zhou F, Tan J, et al.

Journal of genetics 2021; (100()).

Chronic kidney disease.

Kalantar-Zadeh K, Jafar TH, Nitsch D, et al.

Lancet (London, England) 2021; (398(10302)):786-802 doi:10.1016/S0140-6736(21)00519-5.

Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice.

Knoers N, Antignac C, Bergmann C, et al.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2022; (37(2)):239-254 doi:10.1093/ndt/gfab218.

Efficacy and safety of dual vs single renin-angiotensin-aldosterone system blockade in chronic kidney disease: An updated meta-analysis of randomized controlled trials.

Zhao M, Qu H, Wang R, et al.

Medicine 2021; (100(35)):e26544 doi:10.1097/MD.0000000000026544.

Sequential genetic testing of living-related donors for inherited renal disease to promote informed choice and enhance safety of living donation.

Thomas CP, Gupta S, Freese ME, et al.

Transplant international : official journal of the European Society for Organ Transplantation 2021; (34(12)):2696-2705 doi:10.1111/tri.14133.

KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD.

Drawz PE, Beddhu S, Bignall ONR, et al.

American journal of kidney diseases : the official journal of the National Kidney Foundation 2022; (79(3)):311-327 doi:10.1053/j.ajkd.2021.09.013.

Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Kidney international 2022; (101(6)):1126-1141 doi:10.1016/j.kint.2022.03.019.

Detecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease.

Okada E, Morisada N, Horinouchi T, et al.

Kidney international reports 2022; (7(4)):857-866 doi:10.1016/j.ekir.2021.12.037.

Hypertension and the kidneys.

De Bhailis ÁM, Kalra PA

British journal of hospital medicine (London, England : 2005) 2022; (83(5)):1-11 doi:10.12968/hmed.2021.0440.

Factors of Poor Prognosis Associated with Chronic Kidney Disease by Stage in Ambulatory Patients: A Cross-sectional Study.

Valdez Ortiz R, Escorza-Valdivia S, Benitez-Renteria S, et al.

Archives of medical research 2022; (53(5)):524-532 doi:10.1016/j.arcmed.2022.06.005.

Autosomal dominant tubulointerstitial kidney disease: A review.

Živná M, Kidd KO, Barešová V, et al.

American journal of medical genetics. Part C, Seminars in medical genetics 2022; (190(3)):309-324 doi:10.1002/ajmg.c.32008.

Complications in Patients with Chronic Kidney Disease.

Lowe KM, Cruz JB, Jones KM

Critical care nursing clinics of North America 2022; (34(4)):395-407 doi:10.1016/j.cnc.2022.07.005.

CKD Progression and Economic Burden in Individuals With CKD Associated With Type 2 Diabetes.

Mullins CD, Pantalone KM, Betts KA, et al.

Kidney medicine 2022; (4(11)):100532 doi:10.1016/j.xkme.2022.100532.

Autosomal Dominant Tubulointerstitial Kidney Disease: An Emerging Cause of Genetic CKD.

Econimo L, Schaeffer C, Zeni L, et al.

Kidney international reports 2022; (7(11)):2332-2344 doi:10.1016/j.ekir.2022.08.012.

Genetic evaluation of living kidney donor candidates: A review and recommendations for best practices.

Thomas CP, Daloul R, Lentine KL, et al.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2023; (23(5)):597-607 doi:10.1016/j.ajt.2023.02.020.

Genomics in the kidney clinic.

Doctor GT, Gale DP, Chan MM

Clinical medicine (London, England) 2023; (23(3)):246-249 doi:10.7861/clinmed.2023-RM2.

Genetic Counseling in Kidney Disease: A Perspective.

Stein Q, Westemeyer M, Darwish T, et al.

Kidney medicine 2023; (5(7)):100668 doi:10.1016/j.xkme.2023.100668.

[Classical nephroprotection: Renin angiotensin aldosterone system inhibitors].

Egocheaga MI, Drak Y, Otero V

Semergen 2023; (49 Suppl 1()):102018 doi:10.1016/j.semerg.2023.102018.

The Clinical Utility of Genetic Testing in the Diagnosis and Management of Adults with Chronic Kidney Disease.

Dahl NK, Bloom MS, Chebib FT, et al.

Journal of the American Society of Nephrology : JASN 2023; (34(12)):2039-2050 doi:10.1681/ASN.0000000000000249.

What are the benefits of preemptive versus non-preemptive kidney transplantation? A systematic review and meta-analysis.

Rana Magar R, Knight SR, Maggiore U, et al.

Transplantation reviews (Orlando, Fla.) 2023; (37(4)):100798 doi:10.1016/j.trre.2023.100798.

Two sides of the same coin: a complex presentation of autosomal dominant tubulointerstitial kidney diseases: a literature review and case reports.

Fistrek Prlic M, Huljev Frkovic S, Beck B, et al.

Frontiers in pediatrics 2023; (11()):1283325 doi:10.3389/fped.2023.1283325.

Genetic Spectrum of Polycystic Kidney and Liver Diseases and the Resulting Phenotypes.

Yang H, Sieben CJ, Schauer RS, Harris PC

Advances in kidney disease and health 2023; (30(5)):397-406 doi:10.1053/j.akdh.2023.04.004.

A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) Guidelines for the Management of Arterial Hypertension.

Sarafidis P, Schmieder R, Burnier M, et al.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2024; (39(6)):929-943 doi:10.1093/ndt/gfae041.

Detecting and managing the patient with chronic kidney disease in primary care: A review of the latest guidelines.

Mayne KJ, Hanlon P, Lees JS

Diabetes, obesity & metabolism 2024; (26 Suppl 6()):43-54 doi:10.1111/dom.15625.

Time trends in preemptive kidney transplantation in Europe: an ERA registry study.

Kramer A, Boenink R, Mercado Vergara CG, et al.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2024; (39(12)):2100-2112 doi:10.1093/ndt/gfae105.

Monogenic Kidney Diseases in Adults With Chronic Kidney Disease (CKD).

Eble J, Köttgen A, Schultheiß UT

Deutsches Arzteblatt international 2024; (121(21)):689-695.

A systematic review of symptoms experienced by children and young people with kidney failure.

Jacob Z, Plumb L, Oni L, et al.

Pediatric nephrology (Berlin, Germany) 2025; (40(1)):53-68 doi:10.1007/s00467-024-06465-8.

Proposal of a Modified Classification of Hypertensive Crises: Urgency, Impending Emergency, and Emergency.

Koracevic G, Stojanovic M, Zdravkovic M, et al.

Current vascular pharmacology 2024; (22(3)):180-186 doi:10.2174/0115701611270174231204110557.

Familial juvenile hyperuricemic nephropathy: Revisiting the SLC8A1 gene, in a family with a novel terminal gross deletion in the UMOD gene.

Gonçalves F, Lisboa-Gonçalves P, Quental R, et al.

Nefrologia 2024; (44(4)):576-581 doi:10.1016/j.nefroe.2024.08.002.

Hypertension in Cardiovascular and Kidney Disease: Recent Trends - Treating Two Diseases as One.

De Pascalis A, Tomassetti A, Vetrano D, et al.

Cardiorenal medicine 2024; (14(1)):581-587 doi:10.1159/000541876.

Evaluation for genetic disease in kidney transplant candidates: A practice resource.

Ames EG, Anand PM, Bekheirnia MR, et al.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2025; (25(2)):237-249 doi:10.1016/j.ajt.2024.10.019.

Genetic testing in a national cohort of adults with chronic kidney disease of unknown origin.

de Haan A, Eijgelsheim M, Vogt L, et al.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2025; (40(6)):1225-1233 doi:10.1093/ndt/gfae270.

The Diagnostic Yield of Genomic Sequencing-based Genetic Kidney Disease Testing in Kidney Transplant Candidates: Experience at an Urban US Transplant Center.

Abu Al Rub F, Elsurer Afsar R, Fleetwood VA, et al.

Transplantation 2025; (109(7)):1201-1208 doi:10.1097/TP.0000000000005288.

Typical Clinical Presentation of an Autosomal Dominant Polycystic Kidney Disease Patient with an Atypical Genetic Pattern.

Marzano N, Caprara C, Reis T, et al.

Genes 2024; (16(1)) doi:10.3390/genes16010039.

Chronic kidney disease.

Romagnani P, Agarwal R, Chan JCN, et al.

Nature reviews. Disease primers 2025; (11(1)):8 doi:10.1038/s41572-024-00589-9.

Phenotype and genotype of autosomal dominant tubulointerstitial kidney disease in a Japanese cohort.

Tanaka Y, Nagano C, Sakakibara N, et al.

Clinical and experimental nephrology 2025; (29(6)):788-796 doi:10.1007/s10157-025-02629-4.

Hypertensive Emergency In UMOD-Related Autosomal Dominant Tubulointerstitial Kidney Disease.

Chaudhry T, Sapru S

The Brown journal of hospital medicine 2022; (1(4)):38580 doi:10.56305/001c.38580.

Hypertension management in patients with advanced chronic kidney disease with and without dialysis.

Gonzalez Suarez ML, Arriola-Montenegro J, Rolón L

Current opinion in cardiology 2025; (40(4)):199-205 doi:10.1097/HCO.0000000000001221.

Overview of ADPKD in Pregnancy.

Campbell RE, Edelstein CL, Chonchol M

Kidney international reports 2025; (10(4)):1011-1019 doi:10.1016/j.ekir.2024.12.035.

Managing Hypertension in Chronic Kidney Disease: The Role of Diet and Guideline Recommendations.

Stambolliu E, Iliakis P, Tsioufis K, Damianaki A

Journal of clinical medicine 2025; (14(11)) doi:10.3390/jcm14113755.

New insights in the pathophysiology and treatment of hypertension in autosomal dominant polycystic kidney disease.

Dumont A, Bellien J, Van Wynsberghe M, et al.

Kidney international 2025; (108(4)):592-608 doi:10.1016/j.kint.2025.05.036.

Autosomal Dominant Tubulointerstitial Kidney Disease: A Review.

Bleyer AJ, Kidd KO, Živná M, Kmoch S

American journal of kidney diseases : the official journal of the National Kidney Foundation 2025; (86(5)):677-689 doi:10.1053/j.ajkd.2025.05.015.

Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2025.

Gordon CE, Garimella PS, Perrone RD, Miskulin DC

American journal of kidney diseases : the official journal of the National Kidney Foundation 2025; (86(4)):525-542 doi:10.1053/j.ajkd.2025.05.010.

The Impact of Digital Health Interventions on Psychological Health, Self-Efficacy, and Quality of Life in Patients With End-Stage Kidney Disease: Systematic Review and Meta-Analysis.

Zhu J, Xie J, Luo Y, et al.

Journal of medical Internet research 2025; (27()):e74414 doi:10.2196/74414.

Genetic Testing and Counselling for Hereditary Renal Carcinoma: What Do Clinicians Need to Know?

Re C, Pecoraro A, Stewart GD, et al.

European urology open science 2025; (82()):131-141 doi:10.1016/j.euros.2025.10.009.

Tolvaptan in Autosomal Dominant Polycystic Kidney Disease (ADPKD): a multicenter real life Italian experience.

Econimo L, Toso D, Capasso G, et al.

Clinical kidney journal 2025; (18(11)):sfaf156 doi:10.1093/ckj/sfaf156.

Pros and cons of lower blood pressure targets in chronic kidney disease.

Hernandez MF, Chang TI

Current opinion in nephrology and hypertension 2026; (35(2)):150-155 doi:10.1097/MNH.0000000000001153.

Genetic Testing in Cystic Kidney Disease.

Soraru J, Mallett AJ, McCarthy HJ, Mallawaarachchi A

Kidney360 2026; (7(8)):1909-1914 doi:10.34067/KID.0000001127.

Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of the CONFIDENCE Randomized Trial.

Agarwal R, Green JB, Heerspink HJL, et al.

Journal of the American College of Cardiology 2026; (87(7)):772-784 doi:10.1016/j.jacc.2025.10.049.

Mental health and kidney disease.

Chilcot J, Cogley C, Carswell C, et al.

Nature reviews. Nephrology 2026; (22(5)):363-376 doi:10.1038/s41581-026-01055-3.

Hyperuricemia and elevated creatinine in a child with anemia.

Leventoğlu E, Şimşek A, Keçeci HN

The Turkish journal of pediatrics 2025; (67(6)):904-911 doi:10.24953/turkjpediatr.2025.6313.

Depression, Anxiety, Stress Symptoms and Health-Related Quality of Life in Hemodialysis Patients: Cross-Sectional Findings from a Romanian Cohort.

Luca AL, Militaru F, Văduva CM, et al.

Medicina (Kaunas, Lithuania) 2026; (62(2)) doi:10.3390/medicina62020242.

Genetic kidney disease in adults-the pathologists' perspective.

Paterson AL, Chan MMY, Roufosse C

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2026; (41(8)):1421-1428 doi:10.1093/ndt/gfag047.

Autosomal Dominant Tubulointerstitial Kidney Disease Clinical Trial Simulator: Case Reports of Model-Informed Drug Development.

Ramesh SS, Rogge M, Kim J, et al.

CPT: pharmacometrics & systems pharmacology 2026; (15(5)):e70258 doi:10.1002/psp4.70258.

Autosomal Dominant Tubulointerstitial Kidney Disease: Approach to Diagnosis.

Connaughton DM, Arnaldi M, Kidd KO, Bleyer AJ

Advances in kidney disease and health 2026; (33(1)):37-47 doi:10.1053/j.akdh.2026.04.003.

Autosomal dominant polycystic kidney disease: Current perspectives in 2026.

Pichette M, Park M, Cornec-Le Gall E

La Revue de medecine interne 2026; (47(9)):490-499 doi:10.1016/j.revmed.2026.05.003.

[Progression inhibition in chronic kidney disease].

Weinmann-Menke J, Galle J

Innere Medizin (Heidelberg, Germany) 2026; (67(8)):836-842 doi:10.1007/s00108-026-02145-x.

Fruits, Vegetables, and Legumes: Harnessing the Gut-Kidney Axis in Hypertensive Chronic Kidney Disease.

Agustin M, Hadinata E, Harbuwono DS, et al.

Foods (Basel, Switzerland) 2026; (15(16)) doi:10.3390/foods15162938.